Table 3.
Duration (days) | IgM | NS1* | Both | Total |
---|---|---|---|---|
Probable cases (tested negative) | ||||
n = 5,817, % | n = 4,263, % | n = 1,409, % | N = 11,489, % | |
1–5 | 1,458 (25) | 3,216 (75.4) | 819 (58.1) | 5,493 (47.8) |
6–10 | 3,460 (59.5) | 958 (22.5) | 479 (34) | 4,897 (42.6) |
> 10 | 899 (15.5) | 89 (2.1) | 111 (7.9) | 1,099 (9.6) |
Laboratory-confirmed cases (tested positive) | ||||
n = 898, % | n = 893, % | n = 212, % | N = 2003, % | |
1–5 | 257 (28.6) | 642 (71.9) | 107 (50.5) | 1,006 (50.2) |
6–10 | 530 (59) | 224 (25.1) | 89 (42) | 843 (42.1) |
> 10 | 111 (12.4) | 27 (3) | 16 (7.5) | 154 (7.7) |
The total number of NS1-positive patient may be underestimated because NS1 testing results are available from the year 2013.